Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12:25:100558.
doi: 10.1016/j.lanepe.2022.100558. eCollection 2023 Feb.

Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions

Asalah Alareeki  1   2 , Aisha M M Osman  1   2 , Mohannad N Khandakji  1 , Katharine J Looker  3 , Manale Harfouche  1   2 , Laith J Abu-Raddad  1   2   4   5
Affiliations

Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions

Asalah Alareeki et al. Lancet Reg Health Eur. .

Abstract

Background: Herpes simplex virus type 2 (HSV-2) infection is a globally prevalent, life-long, sexually transmitted infection. This study characterized HSV-2 seroprevalence in Europe for various at-risk populations and proportions of HSV-2 detection in genital ulcer disease (GUD) and in genital herpes. Data on neonatal herpes and HSV-2's contribution to HIV transmission were also reviewed.

Methods: Cochrane and PRISMA guidelines were followed to systematically review, synthesize, and report HSV-2 related findings. The search was conducted in PubMed and Embase databases up to February 20, 2022. Any publication reporting data on the outcome measures was included. Meta-analyses and meta-regressions were conducted.

Findings: 211 relevant reports were identified, including 12 overall incidence measures, 294 overall (813 stratified by factors such as age and sex) seroprevalence measures, 13 overall (15 stratified by sex) proportions of HSV-2 detection in clinically diagnosed GUD, and 70 overall (183 stratified by factors such as age and sex) proportions of HSV-2 detection in laboratory-confirmed genital herpes. Pooled mean seroprevalence was 12.4% (95% CI: 11.5-13.3%) among general populations, 27.8% (95% CI: 17.5-39.4%) among men who have sex with men, 46.0% (95% CI: 40.1-51.8%) among people living with HIV and people in HIV discordant couples, and 63.2% (95% CI: 55.5-70.6%) among female sex workers. Most measures showed heterogeneity in HSV-2 seroprevalence. The pooled mean seroprevalence among general populations increased with age and was 0.65-fold (95% CI: 0.58-0.74) lower in men than women. Seroprevalence decreased by 1% per calendar year. Pooled mean proportions of HSV-2 detection in GUD and in genital herpes were 22.0% (95% CI: 15.3-29.6%) and 66.0% (95% CI: 62.9-69.1%), respectively. HSV-2 detection in genital herpes cases was 1.21-fold (95% CI: 1.10-1.32) higher in men compared to women and decreased by 1% per calendar year. Incidence of neonatal herpes indicated an increasing trend.

Interpretation: Although seroprevalence is declining, a significant proportion of Europe's population is infected with HSV-2. HSV-2 accounts for approximately one-fifth of GUD cases and two-thirds of genital herpes cases. Findings support the need to invest in HSV-2 vaccine development, and sexual and reproductive health services.

Funding: Qatar National Research Fund [NPRP 9-040-3-008] and pilot funding from the Biomedical Research Program at Weill Cornell Medicine in Qatar supported this study.

Keywords: Epidemiology; Europe; Genital herpes; Genital ulcer; HSV-2; Herpes simplex virus; Prevalence; Sexually transmitted infection.

PubMed Disclaimer

Conflict of interest statement

K.J.L. has received funding from GSK and the World Health Organization for work outside of the submitted work. Otherwise all authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of article selection for this systematic review of HSV-2 epidemiology in Europe, per PRISMA guidelines.
See this image and copyright information in PMC

References

    1. Yousuf W., Ibrahim H., Harfouche M., Abu Hijleh F., Abu-Raddad L. Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions. BMJ Glob Health. 2020;5(7) - PMC - PubMed
    1. James C., Harfouche M., Welton N.J., et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–329. - PMC - PubMed
    1. Douglas J.M., Jr., Berman S.M. Screening for HSV-2 infection in STD clinics and beyond: a few answers but more questions. Sex Transm Dis. 2009;36(11):729–731. - PubMed
    1. Johnston C., Corey L. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev. 2016;29(1):149. - PMC - PubMed
    1. Gnann J.W., Jr., Whitley R.J. Genital herpes. N Engl J Med. 2016;375(7):666–674. - PubMed

LinkOut - more resources